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Polymicrobial communities exist throughout the human body and include both 
fungi and bacteria. During disease, cross-kingdom interactions among bacteria, fungi, 
and/or the immune system can alter virulence and lead to complex polymicrobial 
infections. The fungus C. albicans is among the most commonly isolated fungi in the 
context of fungal-bacterial co-infections and is often accompanied by the bacterium P. 
aeruginosa at a variety of sites throughout the body including mucosal tissues such as 
the lung. In vitro, C. albicans and P. aeruginosa have a cyclic, bi-directional, and largely 
antagonistic relationship, but these interactions do not account for the role of the host 
environment in mediating infection dynamics. Current in vivo infection models of C. 
albicans-P. aeruginosa infection demonstrate variable outcomes of infection and remain 
limited for characterizing immunopathology.  
In this study, we exploit the power of the juvenile zebrafish model to 
simultaneously characterize microbe-microbe interactions, microbial virulence, and 
immunopathology during C. albicans-P. aeruginosa mucosal infection to mimic the co-
infected lung. We demonstrate that C. albicans and P. aeruginosa are synergistically
 i 
virulent by using longitudinal analyses of fungal, bacterial and immune dynamics during 
co-infection, and suggest that enhanced morbidity is associated with exacerbated C. 
albicans pathogenesis and elevated inflammation. Altogether, our data suggest that C. 
albicans-P. aeruginosa crosstalk in vivo can benefit both organisms to the detriment of 
the host. This zebrafish infection model provides a foundation for future analyses of 
specific microbial and immune factors in mediating co-infection, and can be extended to 
study other clinically relevant fungal-bacterial infections by addressing unique questions 
regarding tri-kingdom interactions during polymicrobial infection. 
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CHAPTER 1 
INTRODUCTION 
1.1. Overview 
 Polymicrobial communities exist throughout the human body and include both 
fungi and bacteria. In the event of disease, interactions between fungi and bacteria that 
occupy similar niches within the host can lead to complex, difficult-to-treat polymicrobial 
infections. Candida albicans is among the most commonly isolated fungi in the context 
of fungal-bacterial co-infections, and is often accompanied by the bacterium 
Pseudomonas aeruginosa at a variety of infection sites including mucosal tissues such 
as the lung. During co-infection, alterations in virulence mechanisms and disease can 
be due to C. albicans, P. aeruginosa, the immune system, or any combination of these 
components mediating tri-kingdom interactions.  
Both microbial species are equipped with specific virulence factors to enhance 
their pathogenesis, and in vitro it has been shown that these factors are modified by 
cyclic, bi-directional interactions that occur between C. albicans and P. aeruginosa in 
co-culture. However, the characterized in vitro interactions do not account for influences 
of the host environment in mediating infection dynamics, and thus in vivo models are 
necessary to determine how microbe-microbe interactions in vitro relate to those that 
occur in vivo. Interestingly, previous in vivo studies have shown that C. albicans-P. 
aeruginosa co-infection can result in both antagonistic and synergistic interactions 
depending on the context. In addition to these disparate observations, immune system 
contributions to infection progression, such as immunopathology, remain largely 
uncharacterized due to technical limitations in existing in vivo models.  
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In an effort to bridge the gap between in vitro and in vivo studies of C. albicans-P. 
aeruginosa co-infection, we exploited the juvenile zebrafish; a simpler transparent 
vertebrate model of infection equipped with fully functional innate immunity combined 
with the power to simultaneously track fungal, bacterial, and host components over the 
course of polymicrobial infection. In this study, we use the swimbladder model to mimic 
the co-infected lung environment and address unanswered questions regarding tri-
kingdom interactions of C. albicans-P. aeruginosa mucosal infection to longitudinally 
associate specific fungal, bacterial, and immune factors of co-infection with mortality. 
1.2. Polymicrobial interactions can lead to complex infections 
Polymicrobial communities are ubiquitous throughout the human body and 
include both prokaryotic bacteria and eukaryotic fungi. These ecologically diverse 
microbial systems are located on cutaneous and mucosal surfaces, and in healthy 
individuals, they are tightly regulated by inter-microbial competition and host defense 
mechanisms (Peleg et al., 2010). Imbalances in this regulation often occur in 
immunocompromised individuals and provide a chance for opportunistic pathogens 
such as the fungus Candida albicans and the bacterium Pseudomonas aeruginosa to 
cause life-threatening disease (de Bentzmann and Plésiat, 2011; Kim and Sudbery, 
2011). Given that both fungi and bacteria occupy the same niches within the human 
body, it is likely that polymicrobial infections will develop in susceptible populations. 
Cross-kingdom synergistic or antagonistic interactions between fungi and bacteria can 
significantly impact the outcome of infection and disease progression (Fourie et al., 
2016; Morales and Hogan, 2010; Peleg et al., 2010; Shirtliff et al., 2009). Alterations in 
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virulence mechanisms and disease can be due to bacteria, fungi, the immune system, 
or any combination of these components mediating tri-kingdom interactions. 
1.3. Candida albicans: a major player in polymicrobial infections 
C. albicans is among the most commonly isolated fungi in fungal-bacterial co-
infections (Kim et al., 2015; Valenza et al., 2008). It is a member of the normal flora in 
approximately 50% of the population occupying the skin, oropharyngeal cavity, 
gastrointestinal system, and female reproductive tract (Diekema et al., 2012, 2002; 
Pfaller and Diekema, 2010). In immunocompromised populations, the transition of C. 
albicans from a commensal to pathogenic state can result in a 30-40% mortality rate 
(Ostrosky-Zeichner et al., 2003; Pfaller and Diekema, 2007; Wisplinghoff et al., 2014). 
C. albicans is a polymorphic fungus with the ability to transition from yeast to 
hyphae, an important virulence factor which enables the formation of invasive filaments 
that cause severe host tissue damage and disease (Mayer et al., 2013). C. albicans 
hyphal development is regulated by the production of the quorum sensing molecule 
farnesol (Hornby et al., 2001). Additionally, C. albicans has the ability to form drug-
resistant biofilms, and produces virulence factors such as secreted aspartyl proteases 
and the toxin candidalysin (Mayer et al., 2013; Moyes et al., 2016; Naglik et al., 2003). 
Neighboring bacteria during co-infection can influence these C. albicans virulence 
factors (Gibson et al., 2009; Hall et al., 2011; Hogan et al., 2004; Morales et al., 2013). 
1.4. Pseudomonas aeruginosa accompanies C. albicans during infection 
 The gram-negative aerobic bacterium P. aeruginosa often accompanies C. 
albicans at a variety of infection sites, including burn wounds, contaminated catheters, 
and lung infections (Bauernfeind et al., 1987; Gupta et al., 2005; Hughes and Kim, 
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1973; de Macedo and Santos, 2005; Nseir et al., 2007; Pierce, 2005). P. aeruginosa 
has the unique ability to thrive in most natural and artificial environments including 
water, soil, plants, and animals (Balasubramanian et al., 2013). It is an opportunistic 
pathogen that can infect multiple hosts to cause a variety of acute and chronic infections 
ranging from soft tissue and urinary tract infections to respiratory infections and 
bacteremia (Gellatly and Hancock, 2013). P. aeruginosa is among the most commonly 
isolated pathogens from lung infections including ventilator-associated pneumonia 
(VAP), which can result in a 30% mortality rate (Hidron et al., 2008; Williams et al., 
2010). 
P. aeruginosa is equipped with multiple sophisticated virulence mechanisms 
including swarming motility and biofilm formation (Balasubramanian et al., 2013; 
Bomberger et al., 2009; Gellatly and Hancock, 2013). Furthermore, the production of 
exosomes, quorum-sensing acyl-homoserine lactones (AHLs), and hemolytic 
phospholipase C (PLC) also contribute to P. aeruginosa pathogenesis 
(Balasubramanian et al., 2013; Bomberger et al., 2009; Gellatly and Hancock, 2013). 
The transcription factor LasR is the master regulator of the P. aeruginosa quorum 
sensing system, which senses cell density and controls virulence factor expression 
(Rumbaugh et al., 2000; Schuster et al., 2003). Many of these virulence factors can 
inhibit migration and phagocytosis of innate immune cells including neutrophils, by 
inducing apoptosis and necrosis (Lavoie et al., 2011). The production of P. aeruginosa 
virulence factors can further be altered in the presence of fungi (Gibson et al., 2009; 
Hogan et al., 2004). 
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1.5. C. albicans and P. aeruginosa cause co-infections  
C. albicans and P. aeruginosa are often co-isolated in mucosal tissues, 
especially in patients with cystic fibrosis, a genetic disorder characterized by chronic 
pulmonary infections (Bakare et al., 2003; Bauernfeind et al., 1987; Hughes and Kim, 
1973). Clinical observations suggest that both species influence the other’s virulence 
(Bauernfeind et al., 1987; Gupta et al., 2005; Hughes and Kim, 1973; de Macedo and 
Santos, 2005; Nseir et al., 2007; Pierce, 2005), often resulting in enhanced resistance 
to immune infiltration and therapeutic intervention (Douglas, 2003; Johnson et al., 2016; 
Shirtliff et al., 2009). Furthermore, the risk of developing infections such as ventilator-
associated pneumonia and denture stomatitis is increased when fungal and bacterial 
species co-colonize the host (Azoulay et al., 2006; Baena-Monroy et al., 2005). 
However, information regarding specific interactions between C. albicans and P. 
aeruginosa co-infection and their effects remains sparse and convoluted.  
1.6. C. albicans and P. aeruginosa in vitro interactions are bi-directional  
 The majority of the work conducted to characterize C. albicans-P. aeruginosa 
interactions has been done in vitro to examine physical and molecular alterations of 
both species during co-culture. These in vitro observations suggest that C. albicans-P. 
aeruginosa interactions are bi-directional and highly complex (Figure 1.1). 
 Overall, examination of physical interactions between C. albicans and P. 
aeruginosa has shown that P. aeruginosa adheres to and forms a dense biofilm on C. 
albicans filaments, eventually killing the fungus (El-Azizi et al., 2004; Hogan and Kolter, 
2002). Interestingly, P. aeruginosa does not adhere to or kill the yeast morphology of C. 
albicans (Brand et al., 2008; Hogan and Kolter, 2002). Virulence factors produced by 
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Pseudomonas also contribute to the killing of C. albicans filaments. P. aeruginosa 
secretes hemolytic PLC, which degrades the C. albicans phospholipid 
phosphatidylcholine while generating highly toxic reactive oxygen species (Gibson et 
al., 2009; Hogan and Kolter, 2002). Furthermore, the production of bacterial phenazines 
is toxic to both C. albicans hyphal and yeast morphologies (Gibson et al., 2009). When 
Figure 1.1. C. albicans-P. aeruginosa in vitro interactions 
summarized (adapted from Peleg et al., 2010). 
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co-cultured with C. albicans, P. aeruginosa increases its iron acquisition system and 
produces quorum-sensing AHL molecules that repress the transition of C. albicans from 
yeast to hyphal growth (Hogan et al., 2004; McAlester et al., 2008; Purschke et al., 
2012). 
 Alternatively, C. albicans produces factors that inhibit P. aeruginosa signaling 
and metabolite production (Cugini et al., 2007). C. albicans secreted factors such as 
farnesol inhibit swarming motility in Pseudomonas which can enhance biofilm formation, 
decrease bacterial quorum sensing, and enhance the production of phenazines by P. 
aeruginosa (Chen et al., 2014; Cugini et al., 2007; Gibson et al., 2009; McAlester et al., 
2008). Interestingly, in LasR-defective strains of P. aeruginosa, C. albicans-produced 
farnesol stimulates P. aeruginosa quinolone signaling (Cugini et al., 2010). Altogether, 
these interactions demonstrate the cyclic, bi-directional, and intricate interactions of C. 
albicans and P. aeruginosa in vitro. Cross-kingdom microbial interactions between C. 
albicans and P. aeruginosa can affect virulence factor production and thereby regulate 
threats to the host (Mear et al., 2013; Peleg et al., 2008). To determine how the in vitro 
interactions relate to those that occur in vivo, additional models for the in vivo dissection 
of microbe-microbe interactions are needed. 
1.7. C. albicans-P. aeruginosa co-infection is poorly understood in in vivo models 
Although C. albicans-P. aeruginosa interactions are relatively well-characterized 
in vitro, our understanding of how the host environment and immune response 
contribute to pathogenesis during in vivo co-infection remains extremely limited. 
Interestingly, C. albicans-P. aeruginosa co-infection in different hosts has demonstrated 
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both synergistic and antagonistic outcomes, depending on the context (Mear et al., 
2014; Neely et al., 1986; Peleg et al., 2008). 
Antagonistic interactions have been shown in a Caenorhabditis elegans and 
murine model, demonstrating that the administration of one species protects against 
virulence from the other (Mear et al., 2014; Peleg et al., 2008). The C. elegans study 
showed that infecting worms with C. albicans followed by P. aeruginosa resulted in a 
reduction of invasive C. albicans filaments as compared to the C. albicans 
monoinfection, and thus protected the nematodes from death (Peleg et al., 2008). In the 
more recent murine study, it was shown that pre-infecting the mouse lung with C. 
albicans protected against P. aeruginosa-induced damage by priming the innate 
immune response (Mear et al., 2014). These observations more closely support some 
of the antagonistic relationships described in in vitro studies. 
However, C. albicans-P. aeruginosa co-infection has also been shown to induce 
synergistic virulence in a burn wound murine model (Neely et al., 1986). In this model 
mice were burned, then infected with P. aeruginosa followed by C. albicans, resulting in 
a 60% co-infection mortality rate as compared to the 10% mortality rate in both C. 
albicans and P. aeruginosa mono-infections (Neely et al., 1986). The discrepancy 
among in vivo models suggests that the outcome of P. aeruginosa-C. albicans co-
infections may not be easily predicted from in vitro antagonism and raises important 
questions regarding the role of the host environment in mediating tri-kingdom 
interactions of C. albicans-P. aeruginosa co-infection.  
Polymicrobial infection can stimulate excessive inflammation that causes host 
morbidity and mortality through neutrophil recruitment, cytokine hyperelicitation, 
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pulmonary edema with alveolar collapse, and severe tissue damage in the lung (Allard 
et al., 2009; Mizgerd, 2008; Moldoveanu et al., 2008; Nash et al., 2014; Nayar et al., 
2016; Roux et al., 2013). For example, enhanced expression of the proinflammatory 
cytokine IL-6 has been implicated in elevated pathogenesis during polymicrobial 
infection, including Candida-bacterial co-infection (Chekabab et al., 2015; Condotta et 
al., 2015; Freitas et al., 2009; Nahid et al., 2011; Nash et al., 2014).  
Although host responses and immunopathology are critical components to 
polymicrobial infection outcome, our current understanding of how host immune 
responses play a role in mediating altered pathogenesis in polymicrobial infection 
remains preliminary. In order to address some of these questions, a simpler vertebrate 
model of infection with fully functional innate immunity can be exploited for its ability to 
simultaneously track fungal, bacterial, and host components over the course of 
polymicrobial infection. 
1.8. The zebrafish serves as a powerful in vivo co-infection model 
 The juvenile zebrafish (Danio rerio) has become an increasingly popular model to 
study infectious diseases in recent years. It is an optically transparent vertebrate with 
conserved innate immunity to mammals and is amenable to genetic manipulation, rapid 
in development, and economical (Sullivan and Kim, 2008). Most importantly, the 
transparent nature of the juvenile zebrafish allows for non-invasive visualization of host-
pathogen interactions and spatio-temporal dynamics of infection at high resolution in 
real-time. Characterizing these interactions can be achieved using fluorescent microbes 
and transgenic fish lines that express fluorescent immune cells. Overall, the zebrafish 
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provides both economical and technical advantages over both murine and C. elegans 
models by combining transparency with vertebrate innate immunity. 
 The juvenile zebrafish has been previously used to examine innate immunity 
against C. albicans systemic and mucosal infections and provide insight into specific 
mechanisms of fungal virulence and host defenses (Brothers et al., 2011; Gratacap et 
al., 2013, 2017). Furthermore, the zebrafish has been used to study bacterial virulence, 
pathogenesis, and host responses against P. aeruginosa infection (Brannon et al., 
2009; Clatworthy et al., 2009; Phennicie et al., 2010). Although both C. albicans and P. 
aeruginosa have been independently studied in the zebrafish, no work has been 
conducted to examine the two opportunistic pathogens during co-infection.  
Given that these two microbial species are commonly co-isolated in mucosal 
tissues such as the lung, we developed a C. albicans-P. aeruginosa infection model (as 
described in Chapter 2) to mimic the co-infected lung environment. We did so using our 
previously described juvenile zebrafish swimbladder infection technique (Gratacap et 
al., 2014) to directly administer a mixed culture of C. albicans and P. aeruginosa into the 
swimbladder via microinjection. The swimbladder is an organ that serves for buoyancy 
in the zebrafish and is anatomically, morphologically, and transcriptionally similar to the 
human lung, with an air-epithelial interface that produces surfactants and anti-microbial 
peptides (Cass et al., 2013; Robertson et al., 2014; Winata et al., 2009; Zheng et al., 
2011).  
With the swimbladder model, we have previously shown that during mucosal 
infection C. albicans hyphae cause epithelial invasion and mortality, and that neutrophil 
recruitment and neutrophil extracellular trap formation are important innate immune 
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defenses against C. albicans infection (Gratacap et al., 2013, 2014, 2017). In this study, 
we utilize this simple transparent vertebrate model to address important questions 
regarding tri-kingdom interactions of C. albicans-P. aeruginosa mucosal infection, to 
longitudinally associate specific fungal, bacterial, and immune factors of polymicrobial 
infection with mortality. This model can be used to connect in vitro observations with in 
vivo outcomes of infection by combining the power to examine physical and molecular 
microbial interactions, such as morphology and virulence factor production, with the 
ability to characterize physical, molecular, and cellular immune defenses within the 
complex vertebrate host environment.  
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CHAPTER 2 
CANDIDA AND PSEUDOMONAS INTERACT TO ENHANCE 
MUCOSAL INFECTION IN TRANSPARENT ZEBRAFISH 
2.1. Abstract 
Polymicrobial infections often include both fungi and bacteria, and can 
complicate patient treatment and resolution of infection. Cross-kingdom interactions 
among bacteria, fungi, and/or the immune system during infection can enhance or block 
virulence mechanisms and influence disease progression. The fungus C. albicans and 
the bacterium P. aeruginosa are frequently co-isolated in the context of polymicrobial 
infection at a variety of sites throughout the body, including mucosal tissues such as the 
lung. In vitro, C. albicans and P. aeruginosa have a bi-directional and largely 
antagonistic relationship. Their interactions in vivo remain poorly understood, 
specifically regarding host responses in mediating infection. In this study, we examine 
tri-kingdom interactions using a transparent juvenile zebrafish to model mucosal lung 
infection and show that C. albicans and P. aeruginosa are synergistically virulent. We 
find that high C. albicans burden, fungal epithelial invasion, swimbladder edema, and 
epithelial extrusion events serve as predictive factors for mortality in our infection model. 
Longitudinal analyses of fungal, bacterial and immune dynamics during co-infection 
suggest that enhanced morbidity is associated with exacerbated C. albicans 
pathogenesis and elevated inflammation. The P. aeruginosa quorum sensing deficient 
ΔlasR mutant also enhances C. albicans pathogenicity in co-infection and induces 
extrusion of the swimbladder. Together, these observations suggest that C. albicans-P. 
aeruginosa crosstalk in vivo can benefit both organisms to the detriment of the host. 
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2.2. Materials and Methods 
2.2.1. Zebrafish care and maintenance  
Adult zebrafish used for breeding embryos were housed in recirculating systems 
(Aquatic Habitats, Apopka, FL) at the University of Maine Zebrafish Facility. All 
zebrafish care protocols and experiments were performed in accordance with NIH 
guidelines under Institutional Animal Care and Use Committee (IACUC) protocol A2015-
11-03. Larvae were reared at a density of 150/dish in 150 mm petri dishes containing 
150 ml of E3 (5 mM sodium chloride, 0.174 mM potassium chloride, 0.33 mM calcium 
chloride, 0.332 mM magnesium sulfate, 2 mM HEPES in Nanopure water, pH = 7) 
supplemented with 0.02 mg/ml of 1-phenyl-2-thiourea (PTU) (Sigma-Aldrich, St. Louis, 
MO) to prevent pigmentation, and 0.3 mg/l methylene blue (VWR, Radnor, PA) for the 
first 24 hours to prevent microbial growth. Larvae were manually dechorionated at 24 
hours post-fertilization, transferred into media containing E3 and PTU, and incubated at 
33°C over the course of experiments. This temperature was chosen as the highest safe 
temperature for zebrafish health, regularly used for experiments with temperature-
sensitive alleles. Experiments were conducted using wild-type (AB) zebrafish and 
Tg(mpx:EGFP) (Renshaw et al., 2006) transgenic fish expressing enhanced green 
fluorescent protein in neutrophils. 
2.2.2. Strains and growth conditions 
The Caf2-FR C. albicans strain was constructed by transforming the Caf2-1 
strain (Fonzi and Irwin, 1993) with the pENO1-iRFP-NATR plasmid. The pENO1-iRFP-
NATR plasmid contains a codon-optimized version of the iRFP670 gene (Shcherbakova 
and Verkhusha, 2013) under the control of the constitutive ENO1 promoter, with a 
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nourseothricin resistance marker (NATR). Codon-optimized iRFP670 was ordered from 
Genscript, was digested with Nco1 and Pac1, and cloned into Peno1-dTomato 
(Gratacap et al., 2013). C. albicans transformation was produced using the lithium 
acetate protocol previously published (Gietz et al., 1995) with nourseothricin resistance 
as a selection marker (100 μg/mL NAT, Werner Bioagents, Jena, Germany). At least 10 
colonies were selected and screened for fluorescence via epifluorescence microscopy 
and flow cytometry (640 nm excitation laser, 670/30 emission filter) on an LSRII 
cytometer (Becton Dickinson, Franklin Lakes, NJ). Correct integration of the pENO1-
iRFP-NATR plasmid was confirmed using primers PENO1 Fw (5’-
TCCTTGGCTGGCACTGAACTCG-3’) and iRFP Rv (5’-
ATCACATGAAGTCAAATCAACTTTTCTAGC-3’). 
C. albicans was grown on yeast-peptone-dextrose (YPD) agar (Difco, Livonia, 
MI; 20 g/l peptone, 10 g/l yeast extract, 20 g/l glucose, 2% agar) for 48 hours on solid 
media at 30°C. For infections, liquid cultures of C. albicans were grown by rotating 
overnight in YPD at 30°C. Overnight cultures were washed twice and resuspended in 
calcium- and magnesium-free phosphate-buffered saline (PBS; Lonza, Walkersville, 
MD). C. albicans was subsequently stained with fluorescein-5-isothiocyanate to 
enhance inoculum quantification by microscopy (1.67 mg/ml; FITC; Molecular Probes, 
Eugene, OR) in PBS with sodium bicarbonate (0.037 M final concentration, pH = 8.2), 
incubating C. albicans in the dark for one hour with occasional vortexing. The culture 
was then washed four times in PBS and resuspended in PBS. Using a hemocytometer, 
C. albicans concentration was measured and adjusted to 2.5 x 107 cfu/ml and 5 x 107 
cfu/ml for single and co-infection (unless otherwise specified) respectively, in PBS with 
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5% w/v polyvinylpyrrolidone (PVP) (Sigma-Aldrich, St. Louis, MO) to ensure a 
consistent small-volume injection dose with large particles such as yeast. 
A red-fluorescent protein expressing derivative of Pseudomonas aeruginosa 
clinical isolate strain PA14 (PA14-dTom; (Singer et al., 2010)) or the PA14-derived 
DlasR , transformed with the same plasmid, was grown on LB media (BD, San Jose, 
CA; 10 g/l Bacto tryptone, 5 g/l Bacto yeast extract, 10 g/l sodium chloride, 1.2% agar) 
supplemented with 750 μg/ml ampicillin (EMD Millipore, Billerica, MA) overnight at 37°C. 
For infections, liquid cultures of P. aeruginosa were grown by rotating overnight in LB-
Amp (750 μg/ml) at 37°C. Overnight cultures were washed twice and resuspended in 
PBS. P. aeruginosa concentration was determined using a spectrophotometer to 
measure OD600 of culture and adjusted to 2.5 x 108 cfu/ml and 5 x 108 cfu/ml for single 
and co-infections, respectively, in 5% w/v PVP.  
2.2.3. UV-inactivation of cultures 
Caf2-FR C. albicans and PA14-dTom liquid cultures were grown overnight, 
washed and resuspended in PBS, and concentrations for C. albicans and P. aeruginosa 
were calculated as described above. A volume of 2 ml from each overnight culture was 
taken to UV-inactivate 2.5 x 107 cfu/ml of C. albicans and 1 x 109 cfu/ml of P. 
aeruginosa, placed in uncovered 100 mm x 15 mm polystyrene petri dishes (Fisher 
Scientific, Waltham, MA) and exposed to 100,000 μJ/cm2 four times using a CL-1000 
Ultraviolet Crosslinker (UVP, Vernon Hills, IL), swirling cultures in between exposures. 
After UV-inactivation, cultures were stained with FITC as described above and adjusted 
to 5 x 107 cfu/ml and 5 x 108 cfu/ml for C. albicans and P. aeruginosa, respectively, to 
be mixed prior to swimbladder injection. UV-inactivation was confirmed by plating C. 
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albicans and P. aeruginosa inactivated and live liquid cultures on YPD and LB-Amp 
(750 μg/ml), respectively (including PBS control) to confirm lack of growth. 
2.2.4. Swimbladder infections via microinjection 
At four days post-fertilization, zebrafish larvae were anesthetized in Tris-buffered 
tricaine methane sulfonate (Tricaine; 160 μg/ml; Western Chemicals, Inc., Frendale, 
WA) and selected for swimbladder inflation. Larvae were transferred to E3 containing 
PTU and 0.033 % v/v dimethyl sulfoxide (DMSO, Fisher Bioreagents, Pittsburgh, PA), to 
allow future experiments to be conducted using dexamethasone in DMSO vehicle for 
repetition in an immunocompromised model. Fish were microinjected as previously 
described (Gratacap et al., 2014) with a 5 nl volume of either PVP control, C. albicans at 
2.5 x 107 cfu/ml, P. aeruginosa at 2.5 x108 cfu/ml, or a C. albicans + P. aeruginosa 
mixture at 2.5 x 107 cfu/ml and 2.5 x108 cfu/ml, respectively. The C. albicans + P. 
aeruginosa co-culture was prepared by combining equal volumes of C. albicans at 5 x 
107 cfu/ml and P. aeruginosa at 5 x 108 cfu/ml prior to injection. Within one hour of 
injection, larvae were screened and selected to ensure proper inocula and neutrophil 
fluorescence using a Zeiss Axiobserver Z1 microscope equipped with Vivatome system 
(Carl Zeiss Microimaging, Thornwood, NJ). For mortality experiments, fish were kept at 
33°C in E3 containing PTU out to 96 hours post-injection then euthanized by Tricaine 
overdose. 
2.2.5. Confocal laser-scanning fluorescence microscopy 
At 24 and 48 hours post-injection, larvae were anesthetized in Tricaine and 
immobilized in 0.5% low-melting-point agarose (Lonza, Switzerland) in E3 containing 
Tricaine in a 96-well glass-bottom imaging dish (Greiner Bio-One, Monroe, NC). 
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Confocal images were acquired using an Olympus IX-81 inverted microscope with an 
FV-1000 laser scanning confocal system (Olympus, Waltham, MA). The EGFP, 
dTomato, and Far-Red fluorescent proteins were detected by laser/optical filters with a 
10x (NA 0.4), 20x (NA 0.7) or 40x objective (NA 0.9) for excitation/emission at 488 
nm/505-525 nm, 543 nm /560-620 nm, and 635 nm/655-755 nm, respectively. Images 
were collected and processed using Fluoview (Olympus, Waltham, MA), Photoshop 
(Adobe Systems, Inc., San Jose, CA) and processed in ImageJ (Schindelin et al., 
2012). For burden quantification, acquisition parameters were consistent for all images 
collected. 
2.2.6. RNA isolation and qPCR analysis 
Total RNA was isolated from 6-10 whole larvae per group in three independent 
experiments, using a combination of Trizol (Invitrogen, Carlsbad, CA) and Direct-zol 
RNA Miniprep kit (Zymo Research, Irvine, CA). Briefly, the Direct-zol RNA isolation 
protocol was followed and the Trizol/ethanol mixture containing RNA was transferred to 
a Zymo-Spin IIC Column, followed by the manufacturer’s recommended wash steps. 
Total RNA was eluted in 25 μl of nuclease-free water and stored at −80°C. cDNA was 
synthesized from 500 ng of RNA per sample using iScript Reverse Transcription 
Supermix for RT-qPCR (Bio-Rad, Hercules, CA). qPCR primers used are shown in 
Table 2.1. A CFX96 thermocycler (Bio-Rad, Hercules, CA) was used with the following 
conditions:  95°C for 35 seconds, followed by 40 cycles of 95°C for 5 seconds, and 
60°C for 20 seconds; the final step included 95°C for 10 seconds followed by 65°C for 5 
seconds and included a dissociation curve. Threshold cycles (Ct) and dissociation curve 
were analyzed with Bio-Rad CFX Manager software. Gene expression levels were 
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normalized to zebrafish gapdh (ΔCt) and compared to the non-infected controls (ΔΔCt). 
Fold induction (2ΔΔCt) is represented. 
Table 2.1. qPCR primer information 
Gene Sequence (5’-3’) Reference 
gapdh Fw:TGGGCCCATGAAAGGAAT 
Rv: ACCAGCGTCAAAGATGGATG 
Gratacap et al., 2013 
IL-6 Fw: GGACGTGAAGACACTCAGAGACG 
Rv: AAGGTTTGAGGAGAGGAGTGCTG 
This study 
IL-8 Fw:TGCATTGAAACAGAAAGCCGACG 
Rv: ATCTCCTGTCCAGTTGTCATCAAGG 
This study 
IL-17a Fw: CAATCTGAGGACGGAAAGGG 
Rv: ACTGGGCTTCAAAGATGACC 
This study 
IFN-γ Fw: TGGGCGATCAAGGAAAACGA 
Rv: TTGATGCTTTAGCCTGCCGT 
This study 
TNF-α Fw: CGCATTTCACAAGCGAATTT 
Rv: CTGGTCCTGGTCATCTCTCC 
Gratacap et al., 2013 
 
2.2.7. CFU assessments 
For CFU quantification, 3-4 representative infected larvae were pooled and 
homogenized at 0 hpi and 48 hpi in 500-600 µl of 1x PBS. For plating, 50 µl of 
homogenate from groups was plated on both YPD agar supplemented with 250 µg/ml 
penicillin/streptomycin (Lonza); 30 µg/ml gentamicin sulfate (BioWhittaker, Lonza); 3 
µg/ml vancomycin hydrocholoride (Amresco, Solon, OH) and on Pseudomonas Isolation 
Agar (Sigma-Aldrich) supplemented with 750 ug/ml ampicillin for C. albicans and P. 
aeruginosa selection, respectively. To achieve a countable number of colonies, 
homogenate (neat) and 1:2 (homogenate: 1x PBS) dilutions were plated at 0 hpi, while 
1:5 (homogenate: 1x PBS) and 1:50 (homogenate: 1x PBS) dilutions were plated for the 
48 hpi time point. Plates were incubated overnight at 37°C and colonies were counted 
the following day. 
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2.2.8. Statistical and ImageJ analyses 
To calculate percent of C. albicans and P. aeruginosa covering the swimbladder, 
confocal images acquired at 24 and 48 hpi were processed by manually outlining the 
swimbladder area and calculating the percent covered by C. albicans as a measure of 
microbial fluorescence in ImageJ. Statistical analyses were conducted using Graphpad 
Prism 6 software (Graphpad Software, Inc., La Jolla, CA). 
2.3. Results 
2.3.1. C. albicans and P. aeruginosa actively contribute to synergistic virulence  
C. albicans and P. aeruginosa are opportunistic pathogens co-isolated in 
mucosal tissues, but their interactions have not yet been well characterized during 
mucosal infection. To further examine C. albicans-P. aeruginosa interactions in mucosal 
infection and determine if the host environment may influence outcome of co-infection, 
we adopted our newly described zebrafish swimbladder model (Gratacap et al., 2014) to 
mimic the co-infected lung found in some patients (Leclair and Hogan, 2010). We 
created a mucosal infection of the swimbladder in immunocompetent 4 day post-
fertilization (dpf) zebrafish with C. albicans, P. aeruginosa, and C. albicans + P. 
aeruginosa (co-infection). We used a red fluorescent protein-expressing derivative of 
the P. aeruginosa clinical isolate PA14, and a far-red fluorescent protein-expressing 
derivative of the C. albicans clinical isolate SC5314, as these are both clinical isolates 
with well-characterized virulence in multiple infection models. We found that infection 
with each species alone causes little mortality, but C. albicans and P. aeruginosa are 
synergistically virulent in co-infection. This was the case for both high infection doses 
(Figure 2.1A) and lower doses (Figure 2.1B).  
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Figure 2.1. C. albicans and P. aeruginosa demonstrate synergistic virulence in 
mucosal infection of the swimbladder. (A) Wildtype zebrafish larvae at 4 days post-
fertilization were separated into four groups and microinjected into the swimbladder with 
5 nL of either PVP (control), C. a. at 5 x 107 cfu/mL, P. a. at 2.5 x 108 cfu/mL, or C. a. + 
P. a. at 5 x 107 cfu/mL and 2.5 x 108 cfu/mL, respectively. Fish were screened 
immediately post-injection to select for consistent inocula and mortality was recorded 
every 24 hours out to 96 hours post-injection. Data are representative of 3 pooled, 
independent experiments. Pooled number of individual fish are as follows:  n = 44, 30, 
30, 38 for PVP, C. a., P. a., and C. a. + P. a., respectively. A Kaplan-Meier survival 
analysis with log-rank (Mantel-Cox) test demonstrated a significant reduction in survival 
between C. a. and C. a. + P. a. (p=0.0037). (B,C) Zebrafish larvae were infected as 
described above with either PVP (control), C. albicans at 2.5 x 107 cfu/mL, P. 
aeruginosa at 2.5 x 108 cfu/mL, or C. albicans + P. aeruginosa at 2.5 x 107 cfu/mL and 
2.5 x 108 cfu/mL, respectively. Confocal images were acquired at 10x and 20x 
magnification with scale bars at 100 µm and 200 µm, respectively. Data are 
representative of 4 pooled, independent experiments. Pooled number of individual fish 
are as follows:  n = 98, 58, 49, 58 for PVP, C. a., P. a., and C. a. + P. a., respectively. A 
Kaplan-Meier survival analysis and log-rank (Mantel-Cox) test demonstrate a significant 
reduction in survival between C. a. and C. a. + P. a. (p < 0.0001).  
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Representative images document the high fungal burden and damage in co-infections 
(Figure 2.1C). This mortality difference was also observed in the fluorescent green 
neutrophil transgenic Tg(Mpx:EGFP) fish line used in subsequent experiments (Figure 
2.2). To test if the enhanced virulence associated with co-infection is dependent on live  
organisms, we established co-infections with UV-inactivated bacteria and fungi and 
found that microbial synergy depends on the presence of both live C. albicans and live 
P. aeruginosa (Figure 2.3). Thus, the synergistic virulence of C. albicans-P. aeruginosa 
mucosal infection requires viable fungi and bacteria to exacerbate mortality.  
2.3.2. Immune responses to polymicrobial infection 
Enhanced virulence in co-infection can be due to changes in bacterial or fungal 
behavior, altered interactions with the immune system, or any combination of these 
components that comprise tri-kingdom interactions. Excessive inflammation, including 
immune infiltration, cytokine production and edema can enhance tissue damage and 
mortality in the host, so we utilized the Tg(Mpx:EGFP) fish line to determine whether co-
infection amplifies neutrophilic recruitment. We quantified neutrophil migration to the site 
of infection in individual fish at 24 and 48 hours post-injection (hpi) using confocal 
microscopy. In both C. albicans mono-infection and C. albicans + P. aeruginosa co-
infection, neutrophils were highly recruited to the site of infection, with a slight (but not 
significant) elevation associated with co-infection (Figure 2.4A,B). To determine whether 
neutrophil recruitment can serve as a predictive factor for mortality, individual fish were 
first imaged by confocal microscopy at 24 hpi. Z-stacks were blindly scored for 
neutrophil recruitment as level 1 (low), 2 (medium) or 3 (high), as illustrated in Figure 
2.5A. Then, individuals were monitored for survival until 48 hpi. This analysis found no  
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Figure 2.2. C. albicans and P. aeruginosa synergistic virulence is confirmed in 
Tg(Mpx:EGFP) zebrafish larvae. Tg(Mpx:EGFP) zebrafish larvae at 4 days post-
fertilization were separated into 4 groups and microinjected into the swimbladder with 5 
nL of either PVP (control), C. a. at 5 x 107 cfu/mL, P. a. at 2.5 x 108 cfu/mL, or C. a. + P. 
a. at 5 x 107 cfu/mL and 2.5 x 108 cfu/mL, respectively. Fish were screened immediately 
post-injection to select for neutrophil fluorescence and consistent inocula, and mortality 
was recorded every 24 hours out to 96 hours post-injection. Data are representative of 5 
pooled, independent experiments. Pooled number of individual fish are as follows:  n = 
73, 61, 63, 65 for PVP, C. a., P. a., and C. a. + P. a., respectively. A Kaplan-Meier 
survival analysis with log-rank (Mantel-Cox) test demonstrated a significant reduction in 
survival between C. a. and C. a. + P. a. (p = 0.0001). 
 
 
Figure 2.3. C. albicans and P. aeruginosa actively contribute to synergistic 
virulence. Wildtype zebrafish larvae at 4 days post-fertilization were separated into 4 
groups and microinjected into the swimbladder with 5 nL of the following:  PVP control, 
C. a. (2.5 x 107 cfu/mL) + UV-inactivated (UV-x) P. a. (2.5 x 108 cfu/mL), P. a. (2.5 x 108 
cfu/mL) + UV-x C. a. (2.5 x 107 cfu/mL), or C. a. + P. a. at 2.5 x 107 cfu/mL and 2.5 x 
108 cfu/mL, respectively. Data are representative of 6 pooled, independent experiments. 
Pooled number of individual fish are as follows:  n = 142, 86, 92, 96 for PVP, C. a., C. a. 
+ UV-x P. a., and C. a. + P. a., respectively. A log-rank (Mantel-Cox) test determined a 
significant difference between C. a. + UV-x P. a. and C. a. + P. a. (p = 0.0015). 
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Figure 2.4. Neutrophils are highly recruited in both C. albicans-infected groups. 
Tg(Mpx:EGFP) zebrafish larvae at 4 days post-fertilization were separated into 4 groups 
and microinjected into the swimbladder with 5 nL of either PVP (control), C. a. at 2.5 x 
107 cfu/mL, P. a. at 2.5 x 108 cfu/mL, or C. a. + P. a. at 2.5 x 107 cfu/mL and 2.5 x 108 
cfu/mL, respectively. Fish were screened immediately post-injection to select for 
neutrophil fluorescence and consistent inocula. (A, B) Neutrophils at site of injection 
were quantified and confocal images of representative fish at 20x magnification were 
taken at 24 and 48 hours post-injection, scale bar = 100 μm. Data are pooled from 3 
independent experiments. Total number of individual fish are as follows:  n = 21, 23, 27, 
18 for PVP, C. a., P. a., and C. a. + P. a., respectively. Analysis was conducted using a 
one-way ANOVA with Tukey’s multiple comparisons post-test. 
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correlation between the neutrophil recruitment level and survival in individual fish 
(Figure 2.5B). Thus, there is no excessive neutrophil infiltration in co-infection, and 
neutrophil recruitment is not a predictor for mortality. 
Figure 2.5. Neutrophil recruitment level does not correlate to mortality. 
Tg(Mpx:EGFP) zebrafish larvae infected and screened as previously described. (A, B) 
Confocal images acquired at 24 hpi at 20x magnification were used to stratify fish based 
on neutrophil recruitment (level 1 = low, level 2 = medium, level 3 = high, as 
demonstrated by representative confocal images) and their corresponding survival at 48 
hpi; scale bar = 100 μm. Data are pooled from 3 independent experiments; n = 21, 23, 
27, 18 for PVP, C. a., P. a., and C. a. + P. a., respectively. No significant differences 
were observed according to a Fisher’s Exact analysis. 
 
Another key cause and indicator of pathogenic inflammation is proinflammatory 
cytokine and chemokine release. Therefore, we examined a number of well-known 
proinflammatory cytokines and chemokines associated with polymicrobial infection, 
including TNF-α, IL-17, IFN-γ, IL-8, and IL-6 (Figure 2.6A,B). Of the assessed 
proinflammatory mediators, we found infection-associated increases in the expression 
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of both IL-8 and IL-6 (Figure 2.6B). The chemokine IL-8 is a potent neutrophil 
chemoattractant (Hammond et al., 1995) and its expression displayed a similar trend to 
our neutrophil recruitment data, with a slight but not statistically significant elevation 
(Figure 2.6B). The proinflammatory cytokine IL-6 is produced by several cell types and 
has been linked to edema, sepsis, and increased mortality in both mono-infections and 
C. albicans-S. aureus co-infection (Nash et al., 2014, 2015; Spittler et al., 2000). 
Interestingly, this proinflammatory cytokine was significantly upregulated in C. albicans-
P. aeruginosa co-infection as compared to the C. albicans mono-infection (Figure 2.6B), 
suggesting that IL-6 proinflammatory gene expression may contribute to increased 
mortality. However, since qPCR is an endpoint assay we were not able to determine if 
higher IL-6 production in individual fish predicted mortality. 
Inflammation and IL-6 production are associated with edema, alveolar collapse, 
and acute lung injury in the lung, suggesting that loss of the air bubble in the 
swimbladder (deflation) may serve as a non-invasive parallel indicator of inflammation 
and edema (Bellingan, 2002; Gratacap et al., 2013; Mizgerd, 2008; Zhang et al., 2016). 
To longitudinally test association of this inflammatory phenotype with mortality, we 
compared the proportion of fish with swimbladder deflation in the single and co-
infections. At both 24 and 48 hpi, a significantly higher percentage of fish had 
swimbladder deflation in the co-infection as compared to mono-infections (Figure 2.7A). 
To further assess the relationship between swimbladder deflation and mortality, 
individual fish were tracked and the incidence of deflation at 24 hpi was correlated to 
their survival at 48 hpi. Fish with deflation had a significantly lower survival rate as  
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Figure 2.6. IL-6 is upregulated during co-infection. Tg(Mpx:EGFP) zebrafish larvae 
infected and screened as previously described. (A, B) Representative fish were 
homogenized at 48 hpi for isolation of total RNA followed by cDNA synthesis for qPCR 
analysis. Expression for genes of interest was normalized to gapdh, with PVP control 
used for reference (ΔΔCt). Fold induction (2ΔΔCt) is represented. Total RNA was 
extracted from 3 independent experiments; total n = 22, 24, 28, 21 larvae for PVP, C. a., 
P. a., and C. a. + P. a. groups, respectively. (A) qPCR for TNF-a was replicated four 
times, while IL-17 and IFN-y was performed once. A one-way ANOVA with Tukey’s 
multiple comparisons post-test showed no differences in expression. (B) qPCR for both 
genes was replicated in triplicate. A one-way ANOVA with Tukey’s multiple comparisons 
post-test, revealed significantly higher IL-6 expression in the co-infection as compared 
to the C. a. mono-infection (p = 0.011); for PVP vs. C. a. p = 0.0963 and for PVP vs. C. 
a. + P. a. p = 0.0005.  
 
 
 
 
 
 
 
p = 0.0963  
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compared to those with inflated swimbladders (Figure 2.7B). Thus, swimbladder 
deflation is higher in co-infection and serves as an early predictive factor for mortality in 
the zebrafish. Together, these experiments link co-infection to enhanced inflammatory 
cytokine responses and suggest that local inflammation may contribute to mortality in C. 
albicans-P. aeruginosa co-infection of the mucosa. 
Figure 2.7. Swimbladder deflation is higher in co-infection and correlates to 
mortality. Tg(Mpx:EGFP) zebrafish larvae infected and screened as previously 
described (A) Percent of fish with swimbladder deflation at 24 and 48 hpi. A Fisher’s 
Exact test, revealed a significantly higher percentage of fish with swimbladder deflation 
in the co-infection as compared to the C. a. mono-infection (p = 0.0437 for 24 hpi, and p 
= 0.0005 for 48 hpi), n = 28 for C. a. and n = 27 for co-infection. (B) Confocal images 
acquired at 24 hpi were stratified based on the survival of individual fish at 48 hpi 
relative to swimbladder deflation; n = 28 with deflation and n = 34 without deflation. 
According to a Fisher’s Exact test, fish that died by 48 hpi had significantly higher 
incidence of swimbladder deflation than those that survived (p < 0.0001).     
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2.3.3. Co-infection morbidity does not result from high P. aeruginosa burden or 
dissemination  
Given that live P. aeruginosa are required for enhanced mortality in co-infection, 
we aimed to further characterize the role of the bacteria in mediating virulence in C. 
albicans-P. aeruginosa infection. We took advantage of the zebrafish larva’s small size 
and transparency to determine if bacteria leave the swimbladder and cause systemic 
disease. However, bacterial dissemination from the swimbladder to other parts of the 
zebrafish was never observed in over 30 experiments (over 300 co-infected fish), 
suggesting that bacteremia is not causing mortality.  
We then measured bacterial burden to determine if C. albicans enhances 
bacterial growth or retention in the swimbladder. To quantify bacterial burden in the 
infected fish, we conducted a colony forming unit (CFU) analysis by homogenizing 
representative fish from each group at 0 and 48 hpi and plating the homogenate on 
selective media. The initial P. aeruginosa load was the same for animals with P. 
aeruginosa alone and with combined P. aeruginosa and C. albicans, but there was a 
significantly higher P. aeruginosa burden at 48 hpi in co-infected fish (Figure 2.8A). To 
investigate the correlation between bacterial burden and death, P. aeruginosa infection 
levels were scored in individual fish as high (level 3), medium (level 2), or low (level 1) 
burden via confocal microscopy at 24 hpi (Figure 2.8B,C). Based on these assigned 
infection levels, there was no statistical difference in bacterial burden between single 
and co-infections. However, there was a trend toward slightly elevated levels of P. 
aeruginosa in the co-infection at 48 hpi as compared to the single infection (Figure 
2.8C). When the infection level at 24 hpi was mapped to survival in individual fish at 48  
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Figure 2.8. P. aeruginosa burden does not directly contribute to mortality.  
Tg(Mpx:EGFP) zebrafish larvae were infected and screened as previously described. 3-
4 representative fish per group were subsequently homogenized for quantifying CFUs of 
P. aeruginosa by using selective media, with the remaining fish followed out to 48 hpi. 
Representative fish were imaged at 24 and 48 hpi via confocal microscopy. (A) Data are 
representative of 6 pooled, independent experiments. A total of 22 individual fish were 
homogenized per time point for CFU quantification and plotted on a log10 scale. A 
Student’s T-test demonstrated a significant increase in number of P. a. between single 
and co-infection groups at 48 hpi (p < 0.00001). (B,C,D) Confocal images acquired at 24 
hpi were blinded and qualitatively scored based on P.a. burden (level 1 = low, level 2 = 
medium, level 3 = high), then individuals were followed to determine their survival at 48 
hpi. Total numbers of fish analyzed: 15 dead, 25 alive at 48 hpi. (B) Representative 
images of each burden level. Fractions in lower left corner indicate the number of fish of 
a given phenotype that were scored at a given time point post-infection (green are P. 
aeruginosa mono-infection; red are P.a. + C. a.). Percentage shown at lower right is 
from ImageJ quantification of burden. (C) No significant differences in average infection 
level were observed between mono- and co-infected fish, based on qualitative scoring 
of Pseudomonas burden, according to a Student’s T-test. (D) No significant differences 
were found in the percentages of fish with different qualitatively-scored levels of P. 
aeruginosa burden, between mono- and co-infected fish, as tested by Fisher’s Exact 
test. (E) Percent swimbladder coverage by P. aeruginosa was quantified via ImageJ 
analysis of microbial fluorescence from confocal images acquired for representative fish 
at 24 hpi. Calculated percent coverage from this analysis is also shown in panel B. For 
fish that died at 48 hpi n = 11 in C. a. + P.a.; fish that lived at 48 hpi n = 4 for P. a. and n 
= 22 for C. a. + P.a. No differences were observed using an unpaired Mann-Whitney 
test. Confocal images were acquired at 20x magnification, scale bar = 100 µm. 
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hpi, no correlation was observed between the level of P. aeruginosa at 24 hpi and 
survival of the fish at 48 hpi (Figure 2.8B,D). P. aeruginosa burden was then 
quantitatively analyzed by microscopy to determine the percent swimbladder coverage 
by the bacteria using ImageJ software to calculate bacterial fluorescence in the outlined 
swimbladder area. Swimbladder coverage was further analyzed relative to fish survival 
and we found that, although there is a trend towards increased P. aeruginosa burden in 
co-infected fish that die by 48 hpi, there is no significant correlation between bacterial 
burden as a measure of swimbladder coverage at 24 hpi and probability of death by 48 
hpi (Figure 2.8E). Taken together, these data indicate that, although levels of P. 
aeruginosa are elevated with the co-infection, within the population of co-infected fish 
there is no relationship between elevated bacterial burden and mortality.  
2.3.4. Co-infection enhances C. albicans virulence in the swimbladder  
Since bacterial pathogenesis was not directly associated with enhanced 
mortality, we investigated whether C. albicans is playing a more direct role in the 
synergistic virulence of co-infection. C. albicans burden was quantified by conducting a 
CFU assay, as previously described for P. aeruginosa. This analysis revealed no 
differences in C. albicans burden between the single and co-infection at 48 hpi (Figure 
2.9A). However, C. albicans filaments risk being under-detected by CFU assays due to 
strong adhesion and cell-cell clustering (Bendel et al., 2003; Saville et al., 2003). 
Therefore, fungal burden was also measured as the percent coverage of the 
swimbladder area by C. albicans using ImageJ software, as described above for P. 
aeruginosa. At 24 hpi, we observed significantly higher swimbladder coverage by C. 
albicans in the co-infection as compared to the C. albicans mono-infection (Figure  
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Figure 2.9. Co-infection enhances C. albicans burden.  Tg(Mpx:EGFP) zebrafish 
larvae infected and screened as previously described, 3-4 representative fish per group 
were subsequently homogenized for quantifying CFUs of C. a. by using selective media, 
with the remaining fish followed out to 48 hpi. Representative fish were imaged at 24 
and 48 hpi via confocal microscopy, and another 3-4 fish per group at 48 hpi were 
homogenized to quantify CFUs as described above. Data are representative of 6-8 
pooled, independent experiments. (A) A total of 22 individual fish were homogenized 
per time point for CFU quantification and plotted on a log10 scale. There was no 
significant difference in C. a. CFUs between single and co-infections, according to a 
Student’s T-test. (B) Median percent coverage of the swimbladder by C. a. was 
quantified via ImageJ analysis of confocal images of representative fish at 24 hpi, n = 55 
and 63 for C. a. and C. a. + P. a. infections, respectively. An unpaired Mann-Whitney 
test revealed a significant difference between C. a. single and co-infection (p = 0.0007). 
(C) Confocal images acquired at 24 hpi were stratified based on the survival of 
individual fish at 48 hpi relative to the median percent swimbladder coverage by C. a., n 
= 18 dead and n = 44 alive, scale bar = 100 µm. According to an unpaired Mann-
Whitney test, fish that died by 48 hpi had significantly higher swimbladder coverage by 
C. a. than those that survived (p < 0.0001). (D) Cumulative frequency distribution plots 
representing percent swimbladder coverage by C. a. at 24 hpi. Fish that died at 48 hpi 
are indicated by red points; C. a. n = 26 and C. a. + P. a. n = 36.  
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2.9B). To further assess the impact of swimbladder coverage by C. albicans on 
mortality, the fish were categorized based on their survival at 48 hpi (Figure 2.9C). Fish 
that died at 48 hpi had significantly more C. albicans swimbladder coverage at 24 hpi 
than fish that survived to 48 hpi (Figure 2.9C). This difference is consistent with 
cumulative plots showing that higher swimbladder coverage at 24 hpi by C. albicans 
correlates to death at 48 hpi (Figure 2.9D). Therefore, there is greater swimbladder 
coverage by C. albicans at 24 hpi in the co-infection and higher early burden is 
associated with mortality.  
The observation that C. albicans burden is more closely associated with mortality 
than immune recruitment or bacterial burden suggests that fungal pathogenesis 
underlies exacerbated mortality in co-infection. Given that a well-known virulence factor 
of C. albicans is hyphal penetration of the host epithelium causing tissue damage 
(Gratacap et al., 2017; Mayer et al., 2013), we assayed fungal epithelial invasion of the 
swimbladder. Overall, there were significantly more fish with invasive C. albicans 
filaments penetrating the epithelium at 24 hpi in the co-infection than in the mono-
infection (Figure 2.10A,B). Furthermore, fish with epithelial invasion at 24 hpi showed 
significantly lower survival to 48 hpi (Figure 2.10C). Therefore, C. albicans epithelial 
invasion may serve as an additional early predictive factor for mortality, occurring more 
frequently during co-infection. Taken together, these data implicate C. albicans 
pathogenesis as a risk factor in co-infection, as indicated by associations of elevated C. 
albicans burden and epithelial invasion with mortality. 
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Figure 2.10. Epithelial invasion is enhanced in co-infection and linked to 
mortality. Tg(Mpx:EGFP) zebrafish larvae infected and screened as previously 
described. (A) Percent of fish with epithelial invasion at 24 hpi; C. a. n = 52 and C. a. + 
P. a. n = 63. According to a Fisher’s Exact test, there was a significant difference 
between C. a. and C. a. + P. a. infection (p = 0.0042). (B, C) Confocal images acquired 
at 24 hpi were quantified by ImageJ and stratified based on the survival of individual fish 
at 48 hpi relative to epithelial invasion by C. a.; n = 15 with invasion and n = 45 without 
invasion. According to a Fisher’s Exact test, fish that died by 48 hpi had significantly 
higher incidence of C. a. invasion than those that survived (p < 0.0001). 
 
2.3.5. P. aeruginosa quorum-sensing deficient ΔlasR mutant enhances mortality 
and C. albicans pathogenicity in co-infection  
Our data suggest that C. albicans virulence is enhanced when combined with live 
P. aeruginosa, so we sought to further investigate how P. aeruginosa is modulating 
fungal pathogenesis. In vitro, P. aeruginosa-produced 3OC12HSL can suppress C. 
albicans virulence in the context of a mixed species biofilm through the lasR-controlled 
production of quorum sensing molecules (Davis-Hanna et al., 2008; Gibson et al., 2009; 
Kerr et al., 1999). In contrast, the production of toxic phenazines are strongly stimulated 
by C. albicans in lasR mutant strains through activation of downstream components of 
the quorum sensing pathway (Cugini et al., 2010). Therefore, the role of P. aeruginosa 
quorum sensing on C. albicans-P. aeruginosa co-infection was assessed using 
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fluorescent derivatives of a lasR-defective (ΔlasR) P. aeruginosa strain (Hogan et al., 
2004) and its parental PA14 wildtype strain. First, we analyzed mortality in co-infections 
of C. albicans and either ΔlasR mutant or the wild-type parental PA14 strain. As 
previously observed, the combination of C. albicans and wild-type P. aeruginosa 
exacerbated mortality as compared to the C. albicans-only infection (Figure 2.11A,B). 
Unexpectedly, the combination of C. albicans and P. aeruginosa ΔlasR showed similar, 
and if anything slightly greater mortality to that of the co-infection with the wild-type 
strain (Figure 2.11A,B). Overall, there was no statistically significant difference in 
survival between the two co-infection groups (wildtype vs. ΔlasR). This suggests that 
the enhanced virulence in co-infections does not depend on lasR-mediated signaling in 
P. aeruginosa, but loss of lasR may even further enhance pathogenesis. 
 To determine if disease progression was altered in ΔlasR co-infections, we 
performed the same longitudinal analyses to evaluate bacterial, fungal or immune 
function in the enhanced virulence of ΔlasR mutant co-infections. CFU analysis 
revealed slightly elevated levels of P. aeruginosa over time in the wild-type co-infection, 
but there was no increase over time in the mutant co-infection (Figure 2.12A), 
suggesting that bacterial burden is even less likely to contribute to enhanced mortality in 
the ΔlasR mutant co-infections. Bacterial dissemination was not seen in these co-
infections, as was the case with the wildtype PA14-C. albicans co-infections.  
CFU analysis of fungal burden revealed that C. albicans levels were slightly 
elevated over time in all cohorts, but there were no significant differences between 
groups (Figure 2.12B). A higher percent swimbladder coverage by C. albicans was 
observed at 24 hpi in both co-infection groups, and if anything to a higher degree in co- 
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infections with the ΔlasR mutant strain (Figure 2.12C). Furthermore, higher C. albicans 
swimbladder coverage correlated with mortality (Figure 2.12D,E). Therefore, we 
conclude that lasR-deficient P. aeruginosa can enhance C. albicans burden, which is 
associated with death. Both C. albicans epithelial invasion and swimbladder deflation 
were enhanced with the co-infection and trended toward a slightly greater enhancement 
with the ΔlasR mutant P. aeruginosa (Figure 2.13A,B). Furthermore, these events 
correlated with higher mortality, as previously observed (Figure 2.13C,D). Overall, these 
data suggest that ΔlasR mutant-enhanced virulence in C. albicans co-infection is 
associated with a similar set of morbidity traits to those already linked to wildtype PA14-
enhanced virulence. 
 A dramatic indicator of enhanced pathogenicity that was pronounced with the 
combination of C. albicans and ΔlasR mutant P. aeruginosa was the occurrence of 
“extrusion events” in which infected tissue containing both C. albicans and P. 
aeruginosa protruded from the side of the fish. To measure these events, confocal 
images acquired at 24 and 48 hpi were analyzed in 3D stacks (Figure 2.14A). 
Interestingly, swimbladder extrusion was observed at a significantly higher frequency at 
48 hpi with the combination of C. albicans and ΔlasR mutant P. aeruginosa (Figure 
2.14B) and early extrusion events were linked to higher mortality (Figure 2.14C). 
Altogether, these data suggest that loss of P. aeruginosa lasR functionality may further 
stimulate C. albicans pathogenicity during co-infection, as indicated by severe fungal 
burden and invasion, swimbladder deflation, and dramatic host epithelial extrusion.  
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Figure. 2.11. P. aeruginosa quorum-sensing deficient ΔlasR mutant enhances co-
infection associated mortality. Tg(Mpx:EGFP) zebrafish larvae at 4 days post-
fertilization were separated into four groups and microinjected into the swimbladder with 
5 nL of either PVP (control), C. a. at 2.5 x 107 cfu/mL, C. a. + P. a. at 2.5 x 107 cfu/mL 
and 2.5 x 108 cfu/mL, respectively, or C. a. + ΔlasR mutant P. aeruginosa at 2.5 x 107 
cfu/mL and 2.5 x 108 cfu/mL, respectively. Fish were screened immediately post-
injection to select for neutrophil fluorescence and consistent inocula. Mortality was 
recorded every 24 hours out to 96 hours post-injection and representative fish were 
imaged at 24 and 48 hpi via confocal microscopy. Data are representative of 5-8 
pooled, independent experiments. (A,B) Kaplan-Meier survival analysis and 
representative images. Pooled number of individual fish are as follows:  n = 96, 61, 71, 
66 for PVP, C. a., C. a. + P. a. and C. a. + ΔlasR P. a., respectively. A log-rank (Mantel-
Cox) test demonstrated a significant reduction in survival between C. a. and C. a. + P. 
a. (p = 0.0002) and C. a. and C. a. + ΔlasR P. a. (p < 0.0001). Images were acquired at 
20x magnification, scale bar = 100 µm.  
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Figure 2.12. P. aeruginosa quorum-sensing deficient ΔlasR mutant enhances C. 
albicans pathogenicity in co-infection. Tg(Mpx:EGFP) zebrafish larvae infected and 
screened as previously described. Data are representative of 8 pooled, independent 
experiments. CFU assessments of P. aeruginosa (A) and C. albicans were conducted 
as previously described. No statistical differences were observed according to a 
Student’s T-test; C. a. n = 41; C. a. + P. a. n = 46; C. a. + ΔLasR P. a. n = 43. (C) 
Median percent coverage of the swimbladder by C. a. was quantified via ImageJ 
analysis of confocal images of representative fish at 24 hpi, n = 41, 44, and 44 for C. a., 
C. a. + P.a. and C.a. + ΔlasR P. a., respectively. According to a Kruskal-Wallis test, 
there was a significant difference between C. a. and C. a. + ΔlasR P. a. infections (p = 
0.0106). (D) Cumulative frequency distribution plots representing percent swimbladder 
coverage by C. a. at 24 hpi. Fish that died at 48 hpi are indicated by red points. (E) 
Median percent coverage of the swimbladder by C. a. is correlated to mortality 
according to an unpaired Mann-Whitney test (p < 0.0001). 
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Figure 2.13. C. albicans epithelial invasion and swimbladder deflation are 
elevated and linked to mortality in ΔlasR P. aeruginosa co-infections. in 
Tg(Mpx:EGFP) zebrafish larvae infected and screened as previously described. Data 
are representative of 8 pooled, independent experiments.  (A) Percent of fish with 
epithelial invasion at 24 hpi, C. a. n = 41; C. a. + P. a. n = 46; C. a. + ΔlasR P. a. n = 43. 
According to a Fisher’s Exact test, there was a significant difference between C. a. and 
C. a. + P. a. infections (p = 0.0435) and between C. a. and C. a. + ΔlasR P. a. (p = 
0.0007). (B) Percent of fish with swimbladder deflation at 24 hpi. According to a Fisher’s 
Exact test, there was a significantly higher percentage of fish with swimbladder deflation 
in the co-infection as compared to the C. a. mono-infection (p = 0.0019) and a 
significant difference between C. a. and C. a. + ΔlasR P. a. (p < 0.0001), n = 41, 46, and 
43 for C. a., C. a. + P. a. and C. a. + ΔlasR P. a., respectively. (D, E) A Fisher’s Exact 
test correlates both epithelial invasion and swimbladder deflation with mortality (p < 
0.0001). 
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Figure 2.14. Co-infection with ΔlasR P. aeruginosa promotes epithelial extrusion 
and is linked to mortality. Tg(Mpx:EGFP) zebrafish larvae infected and screened as 
previously described. Data are representative of 8 pooled, independent experiments. 
Extrusion events were quantified in confocal images. (A) Confocal images were 
acquired at 20x magnification to document extrusion events, scale bar = 100 µm. (B) 
According to a Fisher’s Exact analysis, extrusion events at 48 hpi are significantly 
higher in C. a. + ΔlasR P. a. as compared to C. a. infection (p = 0.0417); for 24 hpi n = 
41, 46, and 43 for C. a., C. a. + P. a. and C. a. + ΔlasR P. a., respectively; for 48 hpi n = 
38, 34, and 29 for C. a., C. a. + P. a. and C. a. + ΔlasR P. a., respectively. (C) Confocal 
images acquired at 24 hpi were quantified by ImageJ and stratified based on the 
survival of individual fish at 48 hpi relative to extrusion events, n = 9 with extrusion and 
n = 121 without extrusion. According to a Fisher’s Exact test, fish that died by 48 hpi 
had significantly higher incidence of extrusion events than those that survived (p = 
0.0099). 	
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CHAPTER 3 
DISCUSSION 
Using our newly developed zebrafish swimbladder model, we showed that 
polymicrobial infection of the mucosa with C. albicans and P. aeruginosa results in 
synergistic virulence that is closely associated with increased C. albicans pathogenesis 
and enhanced inflammation. Overall, the high-content longitudinal imaging in our study 
clearly implicates the fungus and host in co-infection-associated mortality, while 
providing arguments against bacterial dissemination and disease. In the context of co-
infection, we find that C. albicans burden, fungal epithelial invasion, edema, and IL-6 
expression are all associated with the synergistic virulence of C. albicans-P. aeruginosa 
co-infection, while neutrophil recruitment and P. aeruginosa burden are not quantitative 
predictors of infection dynamics. Furthermore, we demonstrated how the loss of LasR 
activity in P. aeruginosa may further stimulate virulence, perhaps due to the absence of 
3OC12HSL production, which can suppress hyphal growth (Hogan et al., 2004), 
combined with the enhanced virulence factor production in the presence of C. albicans 
(Cugini et al., 2010). 
 The synergistic virulence and enhanced filamentous invasion of C. albicans in 
co-infections were unexpected, based on known antagonistic interactions of the two 
microbes in vitro (Peleg et al., 2010). However, the enhanced virulence is consistent 
with most mouse C. albicans-bacterial co-infection models, which result in enhanced 
virulence and fungal invasion (Nash et al., 2014, 2015; Neely et al., 1986; Xu et al., 
2014). Since the same strains of C. albicans and P. aeruginosa were used in these in 
vivo experiments as have been used in vitro, this suggests that the switch from 
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antagonism to synergy is due to the host environment. Many environmental factors are 
both different and dynamic between in vitro and in vivo conditions, including nutrient 
levels, microbe-substrate interactions, cell-cell interactions, secreted products from the 
host, immune pressure, and biophysical effects of the three-dimensional environment 
(Peleg et al., 2010). 
 Our quantitative longitudinal analysis of infection phenotypes revealed that C. 
albicans burden and epithelial invasion are most closely linked to enhanced morbidity in 
the co-infected swimbladder. Similar enhancement of fungal burden and invasion is 
seen in murine C. albicans-bacterial co-infection and epithelial disease models 
(Cavalcanti et al., 2015; Falsetta et al., 2014). This suggests that bacteria stimulate C. 
albicans virulence directly and/or indirectly, through modulation of host activity. 
Increases in fungal burden and filamentous invasion of the epithelium suggest the 
former, while enhanced IL-6 levels and swimbladder edema in co-infected fish are 
consistent with the latter. Given the links between epithelial damage and inflammation, it 
is also possible that epithelial-immune cross-talk also plays an important role in the 
greater pathology of co-infection. 
 The enhanced proinflammatory cytokine induction and swimbladder deflation we 
observe in co-infections suggests that immunopathology plays a role in enhancing co-
infection mortality. The inflammatory role of IL-6 in immunopathology is well-
established, including its association with lethal C. albicans-bacterial intraperitoneal 
infections (Nash et al., 2014, 2015; Peters and Noverr, 2013), but it is not known if this 
cytokine’s action is necessary or sufficient to enhance C. albicans pathogenesis. 
Clinical observations have linked polymicrobial infection to the stimulation of immune 
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cell infiltration, pulmonary edema, acute lung injury, and alveolar collapse—all 
phenotypes that are associated with severe morbidity and mortality in the human lung 
(Johnson et al., 2007; Lange et al., 2013; Mizgerd, 2008; Murakami et al., 2002; Nitta 
and Kobayashi, 1994). The parallels between swimbladder and lung pathologies are 
striking, and suggest that immunopathology may be a factor in enhanced fungal 
virulence of the co-infection. In fact, further analyses of our longitudinal data indicate 
that fungal invasion only occurs in fish with deflated swimbladders (data not shown), 
which is consistent with the idea that swimbladder collapse precedes fungal invasion. 
Although P. aeruginosa burden was higher in co-infections with wildtype bacteria, 
bacterial burden did not correlate with mortality risk and bacterial dissemination was 
never observed. Furthermore, bacterial burden was not higher in ΔlasR mutant co-
infections, despite the strong ability of this mutant to enhance mortality. These results 
indicate that C. albicans may enhance the ability for P. aeruginosa to colonize the site of 
infection without enhancing bacterial virulence, or that co-infection requires only a low 
threshold for P. aeruginosa burden to enhance mortality, either of which would be 
consistent with the LasR-independent ability of P. aeruginosa to promote virulence in 
our model. Depending on the context, infections with LasR-defective P. aeruginosa can 
be more virulent in mice and humans (D’Argenio et al., 2007; Hammond et al., 2016; 
Hoffman et al., 2009, 2010; LaFayette et al., 2015). Interestingly, co-culture of ΔlasR 
mutants with C. albicans restores some bacterial virulence gene expression, suggesting 
that interactions between these two common human commensals might enhance 
pathogenesis (Cugini et al., 2010). 
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Co-infections with ΔlasR mutant bacteria lead to the dramatic extrusion of 
infected swimbladder tissue, although this does not ultimately save them from 
succumbing to infection. Bacterial infections and in vitro co-culture with epithelial layers 
can result in extrusion of individual cells from the epithelium (Golovkine et al., 2016; 
Heiniger et al., 2010; Knodler et al., 2010; Takeuchi et al., 1965), but to our knowledge 
nothing this extreme has yet been described. However, perhaps just as dramatic is the 
ability of humans to extrude foreign objects from the esophagus, through many layers of 
tissue, all the way out of the skin of the neck (Ohbuchi et al., 2012; Shaariyah et al., 
2010). The functional significance of these co-infection-induced events may be host- or 
tissue-dependent, but is tempting to speculate that aspects of extrusion may represent 
a conserved physiological response to certain types of inflammation. 
In summary, this zebrafish mucosal infection model offers high-resolution 
longitudinal analysis as a powerful new tool to disentangle the contributions of the 
immune system and co-infecting bacteria and fungi. The power of this technique is 
illustrated by the ability to demonstrate that P. aeruginosa induces changes that lead to 
enhanced epithelial invasion by C. albicans and death of individual host animals. The 
unexpected finding that P. aeruginosa has a positive influence on C. albicans virulence 
in vivo raises questions about what aspects of infection change this bacterial-fungal 
crosstalk from something antagonistic in vitro into a positive interaction in vivo. 
Hopefully, new in vivo tools and models such as the one described in this study will 
result in a more complete picture of these tri-kingdom interactions in disease. 
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CHAPTER 4 
FUTURE DIRECTIONS 
 Polymicrobial infections including fungi and bacteria involve complex microbe-
microbe and host-microbe interactions, often complicating patient treatment. C. albicans 
and P. aeruginosa are leading players in co-infections and merit more extensive study, 
especially in the context of a live host. In vitro studies of C. albicans-P. aeruginosa co-
infection examine detailed microbe-microbe interactions and virulence, but lack the 
influence of the host environment, while current in vivo studies demonstrate variable 
outcomes of infection depending on the context and are limited for characterizing 
immunopathology. Given the restrictions of simultaneously addressing microbe-microbe 
interactions, microbial virulence, and immunopathology in existing in vivo models, we 
sought to further characterize C. albicans-P. aeruginosa interactions in the zebrafish 
swimbladder to mimic the co-infected lung. 
We were able to characterize some of these tri-kingdom interactions using the 
zebrafish to show that C. albicans-P. aeruginosa polymicrobial infection of the mucosa 
leads to synergistic virulence in vivo. Overall, we demonstrate that the combination of C. 
albicans and P. aeruginosa leads to elevated IL-6 expression, edema, and enhanced C. 
albicans invasion. We also show that the Pseudomonas master quorum sensing 
regulator, LasR, is not essential for increasing C. albicans pathogenicity. To expand 
upon these findings we can explore more in depth roles of IL-6, inflammation and 
immunopathology, fungal morphology, and the production of bacterial virulence factors 
during C. albicans-P. aeruginosa mucosal co-infection, while extending our study to 
other disease models. Having successfully established a zebrafish model for 
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polymicrobial infection, we can further leverage the unique ability to simultaneously 
examine tri-kingdom interactions in the juvenile zebrafish to clarify our understanding of 
these interactions and develop new questions surrounding polymicrobial infection.  
The zebrafish can be utilized to address more specific mechanisms by which 
immune responses mediate infection dynamics of C. albicans-P. aeruginosa infection. 
During polymicrobial infection, excessive host inflammation often causes severe host 
tissue damage, morbidity, and mortality (Allard et al., 2009; Mizgerd, 2008; Moldoveanu 
et al., 2008; Nash et al., 2014; Nayar et al., 2016; Roux et al., 2013). Our data suggest 
that the proinflammatory cytokine IL-6 may be playing a major role in exacerbating 
mortality, perhaps by stimulating excessive inflammation. Additional insight into the role 
of IL-6 can be assessed using a translational-blocking morpholino anti-sense 
knockdown technique to disrupt IL-6 cytokine production (Bill et al., 2009; Summerton 
and Weller, 1997) and determine the consequences of IL-6 loss in the context of co-
infection in the zebrafish. Attenuation of morbidity as a result of IL-6 knockdown would 
support the hypothesis that over-stimulation of IL-6-mediated inflammation during co-
infection plays a pivotal role in exacerbating morbidity and mortality. However, 
morpholino knockdown is administered at the 1-cell stage embryo and results in a 
temporary knockdown. Since we infect fish at 4 days post-fertilization, the knockdown 
has the potential to wear-off prematurely; so alternative means of disrupting IL-6 can be 
achieved using CRISPR technology. Using CRISPR, we could conduct gene editing 
through the induction of a site-specific sequence modification to alter IL-6 receptor 
functionality in the zebrafish (Hwang et al., 2013). Utilizing both techniques to impair IL-
6 functionality would both validate the use of these methods and provide more 
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compelling evidence for the role of IL-6 in mediating the dynamics of C. albicans-P. 
aeruginosa mucosal infection in the zebrafish. 
Furthermore, it would be intriguing to determine how signaling pathways are 
involved in mediating IL-6 production. The production of IL-6 is an important hallmark for 
the activation of the NF-κB transcriptional signaling pathway (Brasier, 2010), and thus 
merits further exploration. We have previously shown that NF-κB activation can serve 
as a marker for epithelial immunity against mucosal candidiasis in the zebrafish using 
Tg(NFκB:EGFP) fish for which NF-κB activation drives green fluorescence (Gratacap et 
al., 2013). Using this zebrafish reporter line would provide the ability to determine 
whether NF-κB expression is elevated with co-infection, potentially providing further 
insight into mechanisms driving exaggerated immune responses with C. albicans-P. 
aeruginosa co-infection. NF-κB activation could be quantified using ImageJ as a tool to 
measure fluorescence as described in Chapter 2.  
We could expand this assessment to investigate spatio-temporal dynamics of 
specific cell-types involved in expression by developing additional transgenic fish lines 
for non-invasive imaging. For example, we could create a reporter line that would 
combine fluorescence expression upon NF-κB activation with fluorescence-driven IL-6 
activation. These analyses would enable us to simultaneously examine both NF-κB and 
IL-6 expression to address specific questions including the location and timing of 
expression during infection. Measuring these expression patterns would not only 
connect underlying NF-κB signaling mechanisms to IL-6 production, but provide 
additional information for the role of mucosal epithelial immunity in response to C. 
albicans-P. aeruginosa infection. 
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Our immune assessments also suggest that neutrophil recruitment does not play 
a significant role in mediating co-infection, but we did not measure neutrophil activity in 
this study. Recent work has shown that neutrophils play an important role in protecting 
the host from C. albicans hyphal tissue invasion during mucosal candidiasis through 
mechanisms including the formation of neutrophil extracellular traps (Gratacap et al., 
2017). We could further examine neutrophil recruitment and activity in response to C. 
albicans-P. aeruginosa co-infection by limiting recruitment through the chemical 
inhibition of CXCR2, which is a major cytokine receptor located on the surface of 
neutrophils. Another strategy would involve using the Rac2-D57N fish line for which 
neutrophil recruitment does not occur, as previously utilized in our laboratory (Gratacap 
et al., 2017). It would be interesting to test whether neutrophils interact differently with 
C. albicans hyphae in the C. albicans mono-infection versus C. albicans-P. aeruginosa 
co-infection, as reduced neutrophil interaction with C. albicans in the context of co-
infection could suggest the formation of a more resistant mixed-species biofilm. 
Comparisons of these C. albicans-neutrophil interactions can be achieved using non-
invasive imaging by confocal microscopy to create 3D reconstructions of neutrophil 
behavior in infected fish. 
However, neutrophils are not the only innate immune cell type that contributes to 
infection dynamics. Macrophages are another important immune cell that functions in 
early response to infection, and thus provide another avenue to examine whether 
excessive inflammation occurs as a result of macrophage recruitment. The 
Tg(mpeg1:mCherry) fish line expressing red fluorescent macrophages would provide an 
excellent resource for tracking macrophage behavior in response to C. albicans-P. 
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aeruginosa infection of the mucosa (Ellett et al., 2011). This fish line has been 
previously used to characterize host-pathogen interactions in the context of mono-
infection, but to our knowledge has not yet been utilized to study polymicrobial infection, 
and would therefore be interesting to pursue (Davis et al., 2016; Jim et al., 2016; 
Mostowy et al., 2013).  
Characterizing immune contributions in mediating co-infection dynamics is crucial 
for understanding complex tri-kingdom interactions, but elucidating microbial factors in 
pathogenicity is equally important. On the fungal side, our data strongly link enhanced 
C. albicans pathogenesis with co-infection mortality, as demonstrated by hyphal tissue 
invasion and swimbladder coverage. Assessing the role of C. albicans morphology 
would provide further evidence for the influence of tissue invasion on mortality in the 
zebrafish model. Our laboratory has constructed fluorescent versions of both a C. 
albicans TET-regulated strain overexpressing NRG1 that blocks filamentation, and a 
TET-regulated strain overexpressing UME6 that drives filamentous growth, resulting in 
“yeast-locked” and “hyperfilamentous” morphologies, respectively. Combining P. 
aeruginosa with these morphological mutants in co-infection would further validate the 
role of C. albicans hyphae-specific tissue invasion in mediating synergistic virulence and 
mortality. 
Although we have strong evidence that C. albicans epithelial invasion is 
contributing to mortality in co-infection, we don’t yet understand how P. aeruginosa is 
enhancing C. albicans pathogenesis. When we combined our fluorescent derivative of 
the P. aeruginosa wild-type clinical isolate PA14 (Rahme et al., 1995) with C. albicans, 
we observed an increase in C. albicans burden and invasion, and interestingly, that 
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increase was further enhanced when C. albicans was combined with the P. aeruginosa 
quorum sensing-deficient ∆lasR mutant. These data indicate that lasR-regulated 
quorum sensing molecules may be dispensable for stimulating C. albicans 
pathogenesis. However, in vitro it has been shown that the presence of C. albicans can 
restore virulence in LasR P. aeruginosa mutants by promoting the production of 
downstream virulence factors (Cugini et al., 2010), which may explain why co-infection 
with the LasR mutant did not attenuate virulence in our co-infection model. Further 
investigation of microbial virulence factor production by methods such as transcriptional 
profiling via RNAseq (Tata et al., 2016) to compare virulence factor expression in wild-
type versus ∆lasR P. aeruginosa during co-infection would be beneficial for this 
analysis.  
P. aeruginosa produces other virulence factors that may be influencing C. 
albicans pathogenesis, including the well-recognized type three secretion system 
(T3SS) (Gellatly and Hancock, 2013). The T3SS allows bacteria to inject exotoxins 
directly into host cells (Gellatly and Hancock, 2013), and this system has been 
previously shown to be required for full P. aeruginosa virulence in a zebrafish model for 
bloodstream infection (Clatworthy et al., 2009). Interestingly, its been demonstrated that 
virulence factors of the T3SS are decreased in C. albicans-P. aeruginosa an intestinal 
model of co-infected mice (Lopez-Medina et al., 2015). However, previous in vitro 
studies indicate that the killing of C. albicans hyphae through cell wall lysis involves both 
P. aeruginosa contact-mediated and soluble factors, suggesting that the T3SS is 
involved in this process (Brand et al., 2008; Matz et al., 2008). It would be informative to 
test whether the combination of a P. aeruginosa T3SS mutant with C. albicans would 
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attenuate or further enhance C. albicans virulence in the context of our mucosal model, 
given that the role of P. aeruginosa T3SS in mediating C. albicans-P. aeruginosa co-
infection remains poorly understood, despite being a leading bacterial virulence factor. 
Investigating this combination would help address the disconnect between mortality of 
co-infection, bacterial burden, and bacterial virulence; which is illustrated by our 
observations of the LasR-independent ability of a low P. aeruginosa burden to promote 
C. albicans virulence and mortality. Investigating how specific P. aeruginosa virulence 
factors like the T3SS affect C. albicans hyphal growth during mucosal co-infection may 
help connect in vitro observations of virulence factor production to morbidity and 
mortality in an in vivo environment. 
A simpler (and more general) means to characterize microbial pathogenicity 
during polymicrobial infection is to modify administered fungal and bacterial doses. In 
our co-infection model, we delivered ten-fold more P. aeruginosa than C. albicans 
based on similar ratios established in previous C. albicans-bacterial co-infection studies 
(Nash et al., 2014; Schlecht et al., 2015; Xu et al., 2014). However, testing different 
concentrations and ratios of fungi to bacteria may provide important information 
regarding the effects of microbe-microbe interactions during live infection. Modifying the 
administration of C. albicans and P. aeruginosa would address whether various fungal-
bacterial ratios dictate the progression and outcome of infection. Furthermore, these 
studies may identify whether there is a threshold of fungi and/or bacteria for establishing 
synergistic virulence. Our data suggest that a low P. aeruginosa threshold may be 
required to enhance C. albicans pathogenesis, as bacterial burden is not predictive of 
mortality. A more detailed investigation of microbial doses and ratios could provide 
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unique information about the influence of microbe-microbe interactions during 
polymicrobial infection that may be overlooked by simply examining microbial virulence 
factors with unchanged inocula. Testing a variety of fungal-bacterial ratios may also 
provide a more complete and representative view of polymicrobial interactions in nature.  
Given the complexity and ecological diversity of the microbiome, another 
important avenue for future work would be to test C. albicans-bacterial co-infections with 
other bacterial species that have implications in polymicrobial diseases of mucosal 
tissues. In our study, we focused on characterizing tri-kingdom interactions in the 
context of C. albicans-P. aeruginosa mucosal co-infection, but many other species are 
found in mixed fungal-bacterial infections (Morales and Hogan, 2010; Peleg et al., 2010; 
Shirtliff et al., 2009). Various studies have been conducted to characterize C. albicans-
bacterial interactions in the mucosa with clinically relevant staphylococci, 
gastrointestinal anaerobic bacteria, and oral streptococci (Adam et al., 2002; Diaz et al., 
2012; Fox et al., 2014; Jenkinson and Douglas, 2002; Nash et al., 2015; Pammi et al., 
2013). It would be interesting to build on our zebrafish model of mucosal infection to 
explore C. albicans-bacterial interactions with other bacteria and compare interactions 
in the zebrafish to previous models, given that C. albicans-bacterial infections 
complicate patient treatment and frequently result in poorer prognosis (Jenkinson and 
Douglas, 2002). For example, blood-borne infections with Candida and bacteria 
including staphylococci and enterococci, result in higher mortality than candidemia 
alone (Dyess et al., 1985). Furthermore, C. albicans and oral bacteria such as 
streptococci and staphylococci are frequently found in the oral mucous of patients 
wearing dental prosthesis (Baena-Monroy et al., 2005), during which synergistic C. 
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albicans-bacterial interactions are observed (Jenkinson and Douglas, 2002). These 
interactions can further result in enhanced C. albicans pathogenicity in biofilms 
containing oral bacteria (Cavalcanti et al., 2015). Examining C. albicans-bacterial co-
infection with these species would enable a greater breadth of knowledge surrounding 
the biology of cross-kingdom fungal-bacterial interactions and provide more detail 
regarding medically important C. albicans interactions with both gram-positive bacteria 
and gram-negative bacteria.  
  In our study, we made efforts to understand a range of tri-kingdom interactions 
during C. albicans-P. aeruginosa co-infection in immunocompetent zebrafish. However, 
many polymicrobial infections occur in immunocompromised individuals, particularly in 
the lungs of patients with cystic fibrosis (Bakare et al., 2003; Bauernfeind et al., 1987; 
Hughes and Kim, 1973). In order to mimic C. albicans-P. aeruginosa co-infection of the 
cystic fibrosis lung, we could utilize the zebrafish swimbladder model in cftr mutant 
transgenic fish (Navis et al., 2013). This line has a defect in the chloride channel cystic 
fibrosis transmembrane conductance regulator to model cystic fibrosis in the zebrafish. 
To our knowledge, this fish line has not been previously utilized to study infection. 
However, a similar cftr study using the zebrafish utilized morpholino knockdown 
technology to show that P. aeruginosa burden is elevated in cftr knockdown fish during 
disseminated infection (Phennicie et al., 2010). Combining the cftr transgenic line with 
our zebrafish swimbladder model to mimic cystic fibrosis lung infection could provide 
unique information regarding in vivo interactions of C. albicans and P. aeruginosa in a 
clinically relevant disease model. 
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 Another important strength of the zebrafish model is that it can be used to 
examine drug treatments in the context of co-infection by simply administering drugs to 
the water in which zebrafish are kept. Fluconazole is commonly used as an anti-fungal 
treatment against C. albicans infection, but drug resistance in the fungus can occur 
(Martin, 1999). Interestingly, preliminary data from our group suggests that the 
combination of C. albicans and P. aeruginosa enhances the efficiency of fluconazole 
against C. albicans growth both in vitro and in the swimbladder. These data raise 
important questions regarding treatment options for C. albicans-P. aeruginosa co-
infection in diseases such as CF by suggesting that fluconazole treatment may be more 
effective at preventing C. albicans-induced damage in the presence of P. aeruginosa. 
Although preliminary, these data further demonstrate the power of the transparent 
zebrafish to develop unique questions with more direct clinical implications. 
In summary, there are many directions and approaches to characterizing tri-
kingdom interactions in the context of polymicrobial infection. Components of host 
responses, fungal pathogenesis, and bacterial pathogenesis must all be considered in 
order to paint a complete picture of the complex interactions that mediate infection 
dynamics. Understanding individual factors and how they contribute to cross-kingdom 
interactions can be achieved using reliable in vivo models such as the zebrafish, and 
will provide essential information for developing more effective treatments for a variety 
of polymicrobial diseases. 
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